LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 7.06 | 27.76 | 4 | 360 | 0.0111 | -0.4079 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 7.06 | 27.76 | 868 | 360 | 2.4111 | 1.5376 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 8.76 | 27.76 | 3 | 401 | 0.0075 | -0.4387 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 8.76 | 27.76 | 745 | 401 | 1.8572 | 1.3486 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 8.76 | 27.76 | 5 | 401 | 0.0125 | -0.3591 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 8.76 | 27.76 | 920 | 401 | 2.2934 | 1.4808 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 10.46 | 27.76 | 12 | 438 | 0.0274 | -0.1899 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 10.46 | 27.76 | 790 | 438 | 1.8010 | 1.3184 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 10.46 | 27.76 | 11 | 438 | 0.0251 | -0.2074 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 10.46 | 27.76 | 1060 | 438 | 2.4165 | 1.4961 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 12.17 | 27.76 | 26 | 489 | 0.0532 | -0.0157 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 12.17 | 27.76 | 792 | 489 | 1.6194 | 1.2470 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 12.17 | 27.76 | 9 | 489 | 0.0184 | -0.2382 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 12.17 | 27.76 | 1033 | 489 | 2.1122 | 1.3960 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 13.87 | 27.76 | 247 | 604 | 0.4085 | 0.6351 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 13.87 | 27.76 | 832 | 604 | 1.3759 | 1.1488 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 13.87 | 27.76 | 14 | 604 | 0.0232 | -0.1427 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 13.87 | 27.76 | 1065 | 604 | 1.7612 | 1.2716 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 15.58 | 27.76 | 363 | 685 | 0.5295 | 0.7432 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 15.58 | 27.76 | 807 | 685 | 1.1771 | 1.0718 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 15.58 | 27.76 | 24 | 685 | 0.0350 | -0.0310 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 15.58 | 27.76 | 1144 | 685 | 1.6687 | 1.2341 | MN20160318_Q01 | N22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 17.28 | 27.76 | 694 | 838 | 0.8275 | 0.9244 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 17.28 | 27.76 | 789 | 838 | 0.9407 | 0.9753 | MN20160318_Q01 | D08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.017783 | 17.28 | 27.76 | 26 | 838 | 0.0310 | -0.0132 | MN20160318_Q01 | N22 |